Remdesivir News and Research

RSS
Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%

Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%

A study on SARS-CoV-2 proteins for the development of COVID-19 drugs

A study on SARS-CoV-2 proteins for the development of COVID-19 drugs

Researchers develop new imaging technique for studying nanoscale coronavirus-host interactions

Researchers develop new imaging technique for studying nanoscale coronavirus-host interactions

Eldelumab and Fenofibrate show potential for COVID-19

Eldelumab and Fenofibrate show potential for COVID-19

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

Researchers identify a novel host-directed therapeutic approach to COVID-19

Researchers identify a novel host-directed therapeutic approach to COVID-19

What lessons have we learned over a year into the COVID-19 pandemic?

What lessons have we learned over a year into the COVID-19 pandemic?

Using AI to fight COVID-19

Using AI to fight COVID-19

The great promise of antiviral peptides against SARS-CoV-2

The great promise of antiviral peptides against SARS-CoV-2

Scientists identify many existing drugs with antiviral activity against coronavirus

Scientists identify many existing drugs with antiviral activity against coronavirus

Known pharmaceutical compounds could provide new therapies for COVID-19

Known pharmaceutical compounds could provide new therapies for COVID-19

Long COVID patients at higher risk of small airway disease

Long COVID patients at higher risk of small airway disease

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

Study links barotrauma to COVID-19 in younger patients

Study links barotrauma to COVID-19 in younger patients

New favipiravir derivative is a potent SARS-CoV-2 inhibitor

New favipiravir derivative is a potent SARS-CoV-2 inhibitor

Could the marine compound plitidepsin promote recovery from moderate COVID-19?

Could the marine compound plitidepsin promote recovery from moderate COVID-19?

Study details challenges and progress toward creating a COVID-19 drug

Study details challenges and progress toward creating a COVID-19 drug

‘Better than the hospital’: Pandemic boosts care for serious illnesses at home

‘Better than the hospital’: Pandemic boosts care for serious illnesses at home

Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication

Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication

Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2

Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2